Zymeworks Inc. Common Stock (ZYME) — Capital Reinvestment Ratio
Zymeworks Inc. Common Stock (ZYME) has a Capital Reinvestment Ratio of 0.07x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.07 Million) in capital expenditures ($884.00K). Check tangible equity quality of Zymeworks Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zymeworks Inc. Common Stock Capital Reinvestment Ratio (2017–2022)
This chart tracks Zymeworks Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ZYME cash flow conversion.
Annual Capital Reinvestment Ratio for Zymeworks Inc. Common Stock (2017–2022)
Year-by-year Capital Reinvestment Ratio for Zymeworks Inc. Common Stock from 2017 to 2022. See Zymeworks Inc. Common Stock (ZYME) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.09x | $144.11 Million | $13.12 Million | ▼ -35.6% |
| 2018 | 0.14x | $24.18 Million | $3.42 Million | ▼ -99.0% |
| 2017 | 14.25x | $219.00K | $3.12 Million | — |